{"id":"https://openalex.org/W2185690990","doi":"https://doi.org/10.1185/03007995.2015.1124075","title":"Q-TWiST analysis of panitumumab plus FOLFOX4 versus FOLFOX4 alone in patients with previously untreated wild-type RAS metastatic colorectal cancer","display_name":"Q-TWiST analysis of panitumumab plus FOLFOX4 versus FOLFOX4 alone in patients with previously untreated wild-type RAS metastatic colorectal cancer","alternate_titles":[],"publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W2185690990","doi":"https://doi.org/10.1185/03007995.2015.1124075","mag":"2185690990","pmid":"https://pubmed.ncbi.nlm.nih.gov/26613286"},"language":"en","primary_location":{"id":"doi:10.1185/03007995.2015.1124075","doi":"https://doi.org/10.1185/03007995.2015.1124075","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007995.2015.1124075","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2185690990"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046008232","display_name":"Jianmin Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jianmin Wang","raw_affiliation_strings":["aRTI Health Solutions, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aRTI Health Solutions, Research Triangle Park, NC, USA","institution_ids":["https://openalex.org/I4210120329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001154948","display_name":"Guy Hechmati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139000","display_name":"Amgen (Switzerland)","ror":"https://ror.org/045wjte67","country_code":"CH","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210139000"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Guy Hechmati","raw_affiliation_strings":["bAmgen GmbH, Zug, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bAmgen GmbH, Zug, Switzerland","institution_ids":["https://openalex.org/I4210139000"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011705581","display_name":"Jun Dong","orcid":"https://orcid.org/0000-0003-3997-8551","observed_orcids":["https://orcid.org/0000-0003-3997-8551"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jun Dong","raw_affiliation_strings":["cAmgen Inc., Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"cAmgen Inc., Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019066502","display_name":"Gregory A. Maglinte","orcid":"https://orcid.org/0000-0001-7130-2557","observed_orcids":["https://orcid.org/0000-0001-7130-2557"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gregory A. Maglinte","raw_affiliation_strings":["cAmgen Inc., Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"cAmgen Inc., Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108620199","display_name":"Beth Barber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Beth Barber","raw_affiliation_strings":["cAmgen Inc., Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"cAmgen Inc., Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114777958","display_name":"Jean\u2010Yves Douillard","orcid":"https://orcid.org/0000-0002-6540-7333","observed_orcids":["https://orcid.org/0000-0002-6540-7333"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Yves Douillard","raw_affiliation_strings":["dICO R. Gauducheau, St Herblain, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"dICO R. Gauducheau, St Herblain, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5046008232"],"corresponding_institution_ids":["https://openalex.org/I4210120329"],"apc_list":null,"apc_paid":null,"fwci":0.7125,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.70115193,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"32","issue":"3","first_page":"459","last_page":"465"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.5181000232696533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.5181000232696533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.4749000072479248,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/panitumumab","display_name":"panitumumab","score":0.984000027179718},{"id":"https://openalex.org/keywords/folfox4","display_name":"FOLFOX4","score":0.9959999918937683},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9829999804496765},{"id":"https://openalex.org/keywords/ras-wild-type","display_name":"RAS wild-type","score":0.9929999709129333},{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.6959999799728394},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.8149999976158142},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.8740000128746033},{"id":"https://openalex.org/keywords/leucovorin","display_name":"leucovorin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5239999890327454},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.5730000138282776},{"id":"https://openalex.org/keywords/utility-weights","display_name":"utility weights","score":0.5730000138282776},{"id":"https://openalex.org/keywords/euroqol-5-dimensions","display_name":"EuroQol-5 Dimensions","score":0.781000018119812}],"concepts":[{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.9090865850448608},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9078391194343567},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.82469642162323},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7764597535133362},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6592918634414673},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5370954275131226},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5360178351402283},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.508892297744751},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4684921205043793},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4453229308128357},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3966888189315796},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.26069408655166626},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21815639734268188}],"mesh":[{"descriptor_ui":"D000077544","descriptor_name":"Panitumumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1185/03007995.2015.1124075","doi":"https://doi.org/10.1185/03007995.2015.1124075","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007995.2015.1124075","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:26613286","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26613286","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1979300931","https://openalex.org/W1990522367","https://openalex.org/W2017005150","https://openalex.org/W2031520822","https://openalex.org/W2042659499","https://openalex.org/W2055929882","https://openalex.org/W2059433414","https://openalex.org/W2085633477","https://openalex.org/W2088915131","https://openalex.org/W2097121246","https://openalex.org/W2098354753","https://openalex.org/W2102844479","https://openalex.org/W2128229739","https://openalex.org/W2134640162","https://openalex.org/W2144648936","https://openalex.org/W2160889655","https://openalex.org/W2161593277","https://openalex.org/W2170430904","https://openalex.org/W2170735473","https://openalex.org/W2254058470","https://openalex.org/W2259708582","https://openalex.org/W2303850172","https://openalex.org/W3041047318"],"related_works":["https://openalex.org/W2999255332","https://openalex.org/W2151483815","https://openalex.org/W2589307761","https://openalex.org/W2921003216","https://openalex.org/W1980070091","https://openalex.org/W2088997205","https://openalex.org/W2337497883","https://openalex.org/W2465958040","https://openalex.org/W2159179344","https://openalex.org/W2075331993"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Panitumumab":[1],"plus":[2,159,182],"infusional":[3],"5-fluorouracil,":[4],"leucovorin,":[5],"and":[6,100,113,144],"oxaliplatin":[7],"(FOLFOX4)":[8],"significantly":[9,155,184],"improved":[10,185],"overall":[11,150],"survival":[12,54,151,187],"versus":[13],"FOLFOX4":[14,160,165,183,190],"alone":[15,166],"in":[16,82,128,141],"patients":[17,174],"with":[18,48,66,157,164,175,189],"previously":[19,176],"untreated":[20,177],"wild-type":[21,178],"RAS":[22,179],"metastatic":[23],"colorectal":[24],"cancer":[25],"(mCRC).":[26],"We":[27,59],"applied":[28,138],"a":[29],"quality-adjusted":[30,53,186],"time":[31,92,140,152],"without":[32,93],"symptoms":[33,94],"of":[34,45,51,95],"disease":[35,96,104],"or":[36,88,97],"toxicity":[37,84,98],"(Q-TWiST)":[38],"analysis":[39],"to":[40,135,139],"provide":[41],"an":[42],"integrated":[43],"measure":[44],"clinical":[46],"benefit,":[47],"the":[49,56,77,83,110,142],"objective":[50],"comparing":[52],"between":[55],"two":[57],"arms.":[58],"acknowledge":[60],"that":[61],"there":[62],"are":[63],"limitations":[64],"associated":[65],"Q-TWIST":[67],"methodology":[68],"for":[69],"crossover":[70],"trials.":[71],"METHODS:":[72],"For":[73],"each":[74],"treatment":[75],"arm,":[76],"truncated":[78],"mean":[79],"times":[80],"spent":[81],"(TOX:":[85],"grade":[86],"3":[87],"4":[89],"adverse":[90],"events),":[91],"(TWiST),":[99],"relapse":[101],"(REL:":[102],"after":[103],"progression)":[105],"states":[106],"were":[107,126,137],"estimated":[108],"by":[109],"product-limit":[111],"method,":[112],"adjusted":[114],"using":[115],"utility":[116,130],"weights":[117,131],"derived":[118],"from":[119,133],"patient-reported":[120],"EuroQol":[121],"5-dimension":[122],"measures.":[123],"Sensitivity":[124],"analyses":[125],"performed":[127],"which":[129],"(varying":[132],"0":[134],"1)":[136],"TOX":[143],"REL":[145],"health":[146],"states.":[147],"RESULTS:":[148],"Quality-adjusted":[149],"was":[153],"statistically":[154],"longer":[156],"panitumumab":[158,181],"(20.5":[161],"months)":[162,168],"than":[163],"(18.2":[167],"(P":[169],"=":[170],"0.025).":[171],"CONCLUSION:":[172],"In":[173],"mCRC,":[180],"compared":[188],"alone.":[191]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2185690990","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
